[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"GPN Vaccines\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100608725","phase-1-serum-collection-study-for-assay-development-100608725",false,"NCT07205289","Serum Collection Study for Assay Development","A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation","Inclusion Criteria:\n\n* good general health\n\nExclusion Criteria:\n\n* no previous pneumococcal vaccine",true,"ALL","18 Years","69 Years",{"count":21,"type":22},12,"ESTIMATED","INTERVENTIONAL",[25],"PHASE1","The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation",[28,29],"Pneumococcal Disease, Invasive","Pneumococcal Disease",[31],"Vaccination pneumococcal","RECRUITING","2025-09-25",{"date":35,"type":36},"2025-10-03","ACTUAL",{"date":38,"type":22},"2025-10",{"date":40,"type":22},"2026-06",{"name":42,"class":43},"GPN Vaccines","INDUSTRY",""]